We are a cross-border private equity firm dedicated to actively pursuing primarily mid- to late-stage U.S. healthcare companies that will benefit from penetrating the vast Asian healthcare market. We identify those well-managed western companies with advanced technology to disrupt the global healthcare market, especially the ones with great market potential in Asia